nach oben

Neurocritical Care

Erschienen in:

01.06.2008 | Review Article

Thrombocytosis in the NICU

verfasst von: David J. Powner, W. Keith Hoots

Erschienen in: Neurocritical Care | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

An elevated platelet count may occur during care of neurology/neurosurgical patients and is usually due to reactive or secondary thrombocytosis (ST) caused by inflammation or infection. Primary (clonal) thrombocythemia or essential thrombocythemia associated with myeloproliferative disorders is usually known before or during early patient assessment. Rarely, paraneoplastic causes of thrombocytosis may be discovered. Although no single test differentiates primary from secondary etiologies, laboratory tests that show increased acute phase responses, such as C-reactive protein, fibrinogen, erythrocyte sedimentation rate, and interleukin-6, may be useful in diagnosing ST. Thrombosis due to ST is rare in any platelet count. ST, however, should be considered within the overall risk assessment for thromboembolism in any patient. If treatment is initiated, low-dose aspirin is sufficient.

Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest. 2005;115:3339–47.PubMedCrossRef

Finazzi G, Harrison C. Essential thrombocythemia. Semin Hematol. 2005;42:230–8.PubMedCrossRef

Campbell PJ, Green AR. The myeloproliferative disorders. N Eng J Med. 2006;355:2452–66.CrossRef

Kato N, Yasukawa K, Onozuka T, Kimura K. Paraneoplastic syndromes of leukocytosis, thrombocytosis, and hypercalcemia associated with squamous cell carcinoma. J Dermatol. 1999;26:352–8.PubMed

Chen CC, Chang JY, Liu KJ, Chan C, Ho CH, Lee SC, Chen LT. Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosis. Ann Oncol. 2005 16:988–9.PubMedCrossRef

Hwang SJ, Luo JC, Li CP, Chu CW, Wu JC, Lai CR, Chiang JH, Chau GY, Liu WY, Lee CC, Chang FY, Lee SD. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol. 2004;10:2472–7.PubMed

Unsal E, Aksaray S, Koksal D, Sipit T. Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis. Postgrad Med J. 2005;81:604–7.PubMedCrossRef

Gofrit ON, Shapiro A, Rund D, Verstandig AG, Landau EH, Katz R, Shenfeld OZ, Gdor Y, Pode D. Thrombocytosis accompanying urinary tract infection suggests obstruction or abscess. Am J Emerg Med. 2006;24:118–21.PubMedCrossRef

Haznedaroglu IC, Ertenli I, Ozcebe OI, Kiraz S, Ozdemir O, Sayinalp NM, Dundar SV, Calguneri M, Kirazli S. Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia. Acta Haematol. 1996;95:107–11.PubMedCrossRef

10.

Griesshammer M, Bangerter M, Sauer T, Wennauer R, Bergmann L, Heimpel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med. 1999;245:295–300.PubMedCrossRef

11.

Shimada H, Oohira G, Okazumi S, Matsubara H, Nabeya Y, Hayashi H, Takeda A, Gunji Y, Ochiai T. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg. 2004;198:737–41.PubMedCrossRef

12.

Chen JL, Afsari K. Reactive thrombocytosis caused by infection. Infect Med. 2002;19:480–3.

13.

Valade N, Decailliot F, Rébufat Y, Heurtematte P. Duvaldestin, Stéphan F. Thrombocytosis after trauma: incidence, aetiology, and clinical significance. Br J Anaesth. 2005;94:18–23.PubMedCrossRef

14.

Saathoff AD, Elkins SL, Chapman SW, McAllister SF, Cleary JD. Thrombocytosis during antifungal therapy of candidemia. Ann Pharmacother. 2005;39:1238–43.PubMedCrossRef

15.

Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003;14:329–31.PubMedCrossRef

16.

Yang CJ, Hwang JJ, Hung JY, Chong IW, Huang MS. Extreme thrombocytosis under the treatment by amoxicillin/clavulanate. Pharm World Sci. 2006;28:326–8.PubMedCrossRef

17.

Hummel MC, Morse BC, Hayes LE. Reactive thrombocytosis associated with enoxaparin. Pharmacotherapy 2006;26:1667–70.PubMedCrossRef

18.

Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006;354:2034–45.PubMedCrossRef

19.

Kirito K, Kaushansky K. Transcriptional regulation of megakaryopoiesis: thrombopoietin signaling and nuclear factors. Curr Opin Hematol. 2006;13:151–6.PubMedCrossRef

20.

Holmin S, Hojeberg B. In situ detection of intracerebral cytokine expression after human brain contusion. Neurosci Lett. 2004;369:108–14.PubMedCrossRef

21.

Woiciechowsky C, Schoning B, Cobanov J, Lanksch WR, Volk HD, Docke WD. Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma 2002;52:339–45.PubMed

22.

Winter CD, Pringle AK, Clough GF, Church MK. Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain 2004;127:315–20.PubMedCrossRef

23.

Kwon KY, Jeon BC. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage. J Korean Med Sci. 2001;16:774–80.PubMed

24.

Takizawa T, Tada T, Kitazawa K, Tanaka Y, Hongo K, Kameko M, Uemura KI. Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subarachnoid hemorrhage. Neurol Res. 2001;23:724–30.PubMedCrossRef

25.

Dziedzic T, Bartus S, Klimkowicz A, Motyl M, Slowik A, Szczudlik A. Intracerebral hemorrhage triggers interleukin-6 and interleurkin-10 release in blood. Stroke 2002;33:2334–5.PubMedCrossRef

26.

Morganti-Kossman MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain injury: a double edged sword. Curr Opin Crit Care 2002;8:101–5.CrossRef

27.

Hsu HC, Tsai WH, Jiang ML, Ho CH, Hsu ML, Ho CK, Wang SY. Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis. J Lab Clin Med. 1999;134:392–7.PubMedCrossRef

28.

Butkiewicz AM, Kemona H, Dymicka-Piekarska V, Matowicka-Karna J, Radziwon P, Lipska A. Platelet count, mean platelet volume and thrombocytopoietic indices in healthy women and men. Thromb Res. 2006;118:199–204.PubMedCrossRef

29.

Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1999;84:613–7.

30.

Aydogan T, Kanbay M, Alici O, Kosar A. Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets 2006;17:328–31.PubMedCrossRef

31.

Buss DH, Cashell AW, O’Connor ML, Richards F 2nd, Case LD. Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med. 1994;96:247–253.PubMedCrossRef

32.

Tefferi A, Hanson CA, Inwards DJ. How to interpret and pursue and abnormal complete blood cell count in adults. Mayo Clin Proc. 2005;80:923–36.PubMed

33.

Rinder HM, Schuster JE, Rinder CS, Wang C, Schweidler HJ, Smith BR. Correlation of thrombosis with increased platelet turnover in thrombocytosis. Blood 1998;91:1288–94.PubMed

34.

Francis CW. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med. 2007;356:1438–44.PubMedCrossRef

35.

Lupia E, Bosco O, Bergerone S, Dondi AE, Goffi A, Oliaro E, Cordero M, Del Sorbo L, Trevi G, Montrucchio G. Thrombopoietin contributes to enhanced platelet activation in patients with unstable angina. J Am Coll Cardiol. 2006;48:2195–203.PubMedCrossRef

36.

Araneda M, Krishnan V, Hall K, Kalbfleisch J, Krishnaswamy G, Krishnan K. Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins. South Med J. 2001;94:417–20.PubMed

37.

Espanol I, Hernandez A, Cortes M, Mateo J, Pujol-Moix N. Patients with thrombocytosis have normal or slightly elevated thrombopoietin levels. Haematologica 1999;84:312–6.PubMed

38.

Hou M, Carneskog J, Mellqvist UH, Stockelberg D, Hedberg M, Wadenvik H, Kutti J. Impact of endogenous thrombopoietin levels on the differential diagnosis of essential thrombocythaemia and reactive thrombocytosis. Eur J Haematol. 1998;61:119–22.PubMedCrossRef

39.

Custodi P, Cerutti A, Balduini CL. Which tests are most useful to distinguish between clonal and reactive thrombocytosis. Am J Med. 1996;101:233–5.PubMedCrossRef

40.

Budman DR, Lackner H, Berczeller P, Silber R. The diagnostic value of the serum lactic dehydrogenase determination in the evaluation of unexplained thrombocytosis. Am J Clin Pathol. 1981;75:840–3.PubMed

41.

Ryningen A, Apelseth T, Hausken T, Bruserud O. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy. Platelets 2006;17:296–302.PubMedCrossRef

42.

Rogers F, Rebuck JA, Sing RA. Venous thromboembolism in trauma: an update for the intensive care practitioner. J Intensive Care Med. 2007;22:26–37.PubMedCrossRef

43.

Linenberger ML, Price TH. Use of cellular, plasma apheresis in the critically ill patient: Part II: Clinical indications and applications. J Intensive Care Med. 2005;20:88–103.PubMedCrossRef

44.

Liumbruno G, Centoni PE, Ceretelli S, Sodini ML. Rapid reduction of platelet numbers in thrombocytosis. Ther Apher. 2000;4:374–6.PubMedCrossRef

45.

Schafer AI. Thrombocytosis. N Engl J Med. 2004;350:1211–9.PubMedCrossRef

Titel: Thrombocytosis in the NICU
verfasst von: David J. Powner
W. Keith Hoots
Publikationsdatum: 01.06.2008
Verlag: Humana Press Inc
Erschienen in: Neurocritical Care / Ausgabe 3/2008
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-008-9076-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

Cardiac Troponin-I: A Predictor of Prognosis in Subarachnoid Hemorrhage

Aggressive Red Blood Cell Transfusion: No Association with Improved Outcomes for Victims of Isolated Traumatic Brain Injury

Combined Intravenous and Intraarterial Revascularization Therapy Using MRI Perfusion/Diffusion Mismatch Selection for Acute Ischemic Stroke at 3–6 h After Symptom Onset

New Insights into the Acute Care of Patients with Aneurysmal Subarachnoid Hemorrhage

Pupillary Reactivity Upon Hospital Admission Predicts Long-term Outcome in Poor Grade Aneurysmal Subarachnoid Hemorrhage Patients